<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html lang="en">
<head>
<title>Source code</title>
<link rel="stylesheet" type="text/css" href="../../../../../../stylesheet.css" title="Style">
</head>
<body>
<div class="sourceContainer">
<pre><span class="sourceLineNo">001</span>package org.biopax.paxtools.model.level3;<a name="line.1"></a>
<span class="sourceLineNo">002</span><a name="line.2"></a>
<span class="sourceLineNo">003</span>/**<a name="line.3"></a>
<span class="sourceLineNo">004</span> * &lt;b&gt;Definition:&lt;/b&gt; An entity feature that represent the covalently bound state of  a physical entity.<a name="line.4"></a>
<span class="sourceLineNo">005</span> *<a name="line.5"></a>
<span class="sourceLineNo">006</span> * Rationale: Most frequent covalent modifications to proteins and DNA, such as phosphorylation and<a name="line.6"></a>
<span class="sourceLineNo">007</span> * metylation are covered by the ModificationFeature class. In these cases, the added groups are<a name="line.7"></a>
<span class="sourceLineNo">008</span> * simple and stateless therefore they can be captured by a controlled vocabulary. In other cases,<a name="line.8"></a>
<span class="sourceLineNo">009</span> * such as ThiS-Thilacyl-disulfide, the covalently linked molecules are best represented as a<a name="line.9"></a>
<span class="sourceLineNo">010</span> * molecular complex. CovalentBindingFeature should be used to model such covalently linked<a name="line.10"></a>
<span class="sourceLineNo">011</span> * complexes.<a name="line.11"></a>
<span class="sourceLineNo">012</span> *<a name="line.12"></a>
<span class="sourceLineNo">013</span> * Usage: Using this construct, it is possible to represent small molecules as a covalent complex of<a name="line.13"></a>
<span class="sourceLineNo">014</span> * two other small molecules. The demarcation of small molecules is a general problem and is<a name="line.14"></a>
<span class="sourceLineNo">015</span> * delegated to small molecule databases.The best practice is not to model using covalent complexes<a name="line.15"></a>
<span class="sourceLineNo">016</span> * unless at least one of the participants is a protein, DNA or RNA.<a name="line.16"></a>
<span class="sourceLineNo">017</span> *<a name="line.17"></a>
<span class="sourceLineNo">018</span> * Examples: disulfide bond UhpC + glc-6P -&amp;gt; Uhpc-glc-6p acetyl-ACP -&amp;gt; decenoyl-ACP charged tRNA<a name="line.18"></a>
<span class="sourceLineNo">019</span> */<a name="line.19"></a>
<span class="sourceLineNo">020</span>public interface CovalentBindingFeature extends BindingFeature, ModificationFeature<a name="line.20"></a>
<span class="sourceLineNo">021</span>{<a name="line.21"></a>
<span class="sourceLineNo">022</span><a name="line.22"></a>
<span class="sourceLineNo">023</span>}<a name="line.23"></a>




























































</pre>
</div>
</body>
</html>
